You are here
,

EMA panel recommends approval of Bluebird Bio's first gene therapy

  • Sunday, 31 March 2019
  • Posted by Aftab Ahmad
  • 0 Comments
A European Medicines Agency panel on Friday recommended a conditional marketing approval for a gene therapy from Bluebird Bio Inc as a genetic blood disorder treatment, setting the stage for the U.S. biotech to win its first regulatory nod.


from Reuters: Health News https://ift.tt/2V4M1KD

Aftab Ahmad

We are.., This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

No comments:

Leave a Reply

Search This Blog

Total Pageviews

427,751